Matches in SemOpenAlex for { <https://semopenalex.org/work/W3209376420> ?p ?o ?g. }
- W3209376420 endingPage "8035" @default.
- W3209376420 startingPage "8025" @default.
- W3209376420 abstract "The dysregulation of microRNAs (miRNAs) and hepatotoxicity due to the aberrant accumulation of bile acids (BAs) are notorious causes that predispose an individual to the development of hepatocellular carcinoma (HCC). Farnesoid X receptor (FXR), encoded by NR1H4 gene, has been identified as a crucial BA receptor to maintain the homeostasis of BA pool and its expression is decreased in HCC. miR-382-5p plays an important role in the pathogenesis of many human malignancies and was reported to promote the proliferation and differentiation of normal liver cells and liver regeneration. However, there is still some controversy about its role in HCC microenvironment. This study aims to explore the expression pattern of miR-382-5p in HCC and its role in regulating FXR during the development of HCC.Tissues collected from 30 HCC patients were subjected to extraction of total RNA and quantitative real-time PCR (qRT-PCR) for the analyses of miR-382-5p expression and NR1H4 mRNA levels, and their expressions were verified by analyzing the online HCC-related GSE datasets. The role of miR-382-5p in regulating cellular proliferation and expression of FXR in different HCC cell lines was analyzed by qRT-PCR, Western Blot, real-time cellular analysis (RTCA) and luciferase reporter assays. The role of miR-382-5p in regulating downstream genes of FXR in HCC cells was also analyzed.miR-382-5p was upregulated in HCC tissues and inversely associated with the downregulation of NR1H4 mRNA levels. The luciferase reporter assay proved that miR-382-5p directly targeted the 3'-untranslated region (3'-UTR) of human NR1H4 mRNA. Overexpression of miR-382-5p led to a malignant proliferation of HCC cells by suppressing the expression of FXR. In contrast, blocking the endogenous miR-382-5p was sufficient to suppress the cellular proliferation rate of HCC through increasing FXR expression. Additionally, miR-382-5p inhibited the expression of some target genes of FXR, including SHP, FGF19 and SLC51A, and this inhibitory effect was FXR-dependent.Therefore, miR-382-5p promotes the progression of HCC in vitro by suppressing FXR and could serve as a valuable therapeutic target for HCC treatment." @default.
- W3209376420 created "2021-11-08" @default.
- W3209376420 creator A5002261203 @default.
- W3209376420 creator A5009931030 @default.
- W3209376420 creator A5020147975 @default.
- W3209376420 creator A5024584263 @default.
- W3209376420 creator A5028033336 @default.
- W3209376420 creator A5033233086 @default.
- W3209376420 creator A5055531138 @default.
- W3209376420 creator A5058073008 @default.
- W3209376420 creator A5067232825 @default.
- W3209376420 creator A5072509983 @default.
- W3209376420 creator A5079654043 @default.
- W3209376420 date "2021-10-01" @default.
- W3209376420 modified "2023-10-16" @default.
- W3209376420 title "miRNA-382-5p Suppresses the Expression of Farnesoid X Receptor to Promote Progression of Liver Cancer" @default.
- W3209376420 cites W14098964 @default.
- W3209376420 cites W1646057852 @default.
- W3209376420 cites W1978779592 @default.
- W3209376420 cites W2007452771 @default.
- W3209376420 cites W2015207387 @default.
- W3209376420 cites W2060881391 @default.
- W3209376420 cites W2063302086 @default.
- W3209376420 cites W2091567890 @default.
- W3209376420 cites W2093900801 @default.
- W3209376420 cites W2113111181 @default.
- W3209376420 cites W2120419639 @default.
- W3209376420 cites W2132593028 @default.
- W3209376420 cites W2134395334 @default.
- W3209376420 cites W2134818519 @default.
- W3209376420 cites W2159496628 @default.
- W3209376420 cites W2186107433 @default.
- W3209376420 cites W2340964572 @default.
- W3209376420 cites W2524537335 @default.
- W3209376420 cites W2563977354 @default.
- W3209376420 cites W2577908664 @default.
- W3209376420 cites W2593458599 @default.
- W3209376420 cites W2709664190 @default.
- W3209376420 cites W2761350327 @default.
- W3209376420 cites W2788271446 @default.
- W3209376420 cites W2805401782 @default.
- W3209376420 cites W2886413802 @default.
- W3209376420 cites W2895464723 @default.
- W3209376420 cites W2901146277 @default.
- W3209376420 cites W2951523994 @default.
- W3209376420 cites W2969802526 @default.
- W3209376420 cites W2970783713 @default.
- W3209376420 cites W2979815966 @default.
- W3209376420 cites W2980411348 @default.
- W3209376420 cites W3021610682 @default.
- W3209376420 cites W3025087299 @default.
- W3209376420 cites W3046441233 @default.
- W3209376420 cites W3083239460 @default.
- W3209376420 cites W3110907039 @default.
- W3209376420 cites W3111128202 @default.
- W3209376420 cites W3119973322 @default.
- W3209376420 cites W3134597494 @default.
- W3209376420 cites W3138927624 @default.
- W3209376420 doi "https://doi.org/10.2147/cmar.s324072" @default.
- W3209376420 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8547345" @default.
- W3209376420 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34712060" @default.
- W3209376420 hasPublicationYear "2021" @default.
- W3209376420 type Work @default.
- W3209376420 sameAs 3209376420 @default.
- W3209376420 citedByCount "7" @default.
- W3209376420 countsByYear W32093764202022 @default.
- W3209376420 countsByYear W32093764202023 @default.
- W3209376420 crossrefType "journal-article" @default.
- W3209376420 hasAuthorship W3209376420A5002261203 @default.
- W3209376420 hasAuthorship W3209376420A5009931030 @default.
- W3209376420 hasAuthorship W3209376420A5020147975 @default.
- W3209376420 hasAuthorship W3209376420A5024584263 @default.
- W3209376420 hasAuthorship W3209376420A5028033336 @default.
- W3209376420 hasAuthorship W3209376420A5033233086 @default.
- W3209376420 hasAuthorship W3209376420A5055531138 @default.
- W3209376420 hasAuthorship W3209376420A5058073008 @default.
- W3209376420 hasAuthorship W3209376420A5067232825 @default.
- W3209376420 hasAuthorship W3209376420A5072509983 @default.
- W3209376420 hasAuthorship W3209376420A5079654043 @default.
- W3209376420 hasBestOaLocation W32093764201 @default.
- W3209376420 hasConcept C104317684 @default.
- W3209376420 hasConcept C111335760 @default.
- W3209376420 hasConcept C127561419 @default.
- W3209376420 hasConcept C145059251 @default.
- W3209376420 hasConcept C150194340 @default.
- W3209376420 hasConcept C161733203 @default.
- W3209376420 hasConcept C203862802 @default.
- W3209376420 hasConcept C2778019345 @default.
- W3209376420 hasConcept C48023723 @default.
- W3209376420 hasConcept C502942594 @default.
- W3209376420 hasConcept C54009773 @default.
- W3209376420 hasConcept C54355233 @default.
- W3209376420 hasConcept C62112901 @default.
- W3209376420 hasConcept C63932345 @default.
- W3209376420 hasConcept C81885089 @default.
- W3209376420 hasConcept C86339819 @default.
- W3209376420 hasConcept C86803240 @default.
- W3209376420 hasConceptScore W3209376420C104317684 @default.